Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-31

Clinical Trial Update: Safety and Efficacy of Oral Artesunate for Pre-cervical Cancer [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study of oral artesunate for cervical intraepithelial neoplasia grade 2/3 (pre-cervical cancer), which is not yet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artesunate (artesunate)

Snippet

Sponsor: Metanoic Health Ltd. | Conditions: CIN 2/3 | Phase 2 | Status: NOT_YET_RECRUITING